|
Volumn 18, Issue 2, 2004, Pages 97-101
|
Effect of Antiparkinson Drug HP-200 (Mucuna pruriens) on the Central Monoaminergic Neurotransmitters
|
Author keywords
Dopamine; Mucuna pruriens; Nigrostriatal tract, rat; Norepinephrine; Parkinson's disease
|
Indexed keywords
3,4 DIHYDROXYPHENYLACETIC ACID;
5 HYDROXYINDOLEACETIC ACID;
ANTIPARKINSON AGENT;
DOPAMINE;
FLAVORING AGENT;
HOMOVANILLIC ACID;
HP 200;
LEVODOPA;
MONOAMINE;
NEUROTRANSMITTER;
NORADRENALIN;
OXIDOPAMINE;
SEROTONIN;
SWEETENING AGENT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN CORTEX;
CONTROLLED STUDY;
CORPUS STRIATUM;
DOPAMINE METABOLISM;
DRUG ABSORPTION;
ELECTROCHEMICAL DETECTION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HIPPOCAMPUS;
MALE;
NONHUMAN;
PARKINSON DISEASE;
RAT;
SUBSTANTIA NIGRA;
VELVET BEAN;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIPARKINSON AGENTS;
BRAIN;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
MALE;
MUCUNA;
NEUROTRANSMITTER AGENTS;
PHYTOTHERAPY;
PLANT EXTRACTS;
RANDOM ALLOCATION;
RATS;
RATS, SPRAGUE-DAWLEY;
ANIMALIA;
MUCUNA;
MUCUNA PRURIENS;
PARKINSONIA;
|
EID: 1642414277
PISSN: 0951418X
EISSN: None
Source Type: Journal
DOI: 10.1002/ptr.1407 Document Type: Article |
Times cited : (58)
|
References (8)
|